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Abstract 
 
The Third-Generation in DNA sequencing has emerged in the last few years using 
new technologies that allow the production of long-read sequences. Applications of 
the Third-Generation sequencing enable real-time and on-site data production, 
changing the research paradigms in environmental and medical sampling in virology. 
To take full advantage of large-scale data generated from long-read sequencing, an 
innovation in the downstream data analysis is necessary. Here, we discuss futuristic 
methods using machine learning approaches to analyze big genetic data. Machine 
learning combines pattern recognition and computational learning to perform 
predictive and exploratory data analysis. In particular, deep learning is a field of 
machine learning that is used to solve complex problems through artificial neural 
networks. Unlike other methods, features can be learned using neural networks 
entirely from data without manual specifications. We discuss the future of 21st-
century virology by presenting futuristic approaches for virus studies using real-time 
data production and on-site data analysis with the Third-Generation Sequencing and 
machine learning methods. We first introduce the basic concepts in conventional 
statistical models and methods in virology, building gradually into the necessity of 
innovating the downstream data analysis to meet the advances in sequencing 
technologies. We argue that artificial neural networks can innovate the downstream 
data analysis, as they can learn from big datasets without model assumptions or 
feature specifications, as opposed to the current data analysis in bioinformatics. 
Furthermore, we discuss how futuristic methods using artificial neural networks 
combined with long-read sequences can revolutionize virus studies, using specific 
examples in supervised and unsupervised settings. 
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1. Virus as Model Organism 
 
Viruses are the most abundant biological entities on Earth, which can infect all types 
of life forms, and only replicate inside cellular organisms. Viruses exploit diverse 
replication-expression strategies, whereas cellular organisms only use double-
stranded DNA as the replicating form and single-stranded RNA as the transcribed 
form [1]. Viruses also display all conceivable genome architectures – single or 
double-stranded, linear or circular, DNA or RNA, monopartite or multipartite – with 
sizes spanning three orders of magnitude [1]. Many viral pathogens exhibit complex 
evolutionary trajectories during transmission between hosts and diversification within 
them: they may experience strong inter-host population bottlenecks and rapid intra-
host population growth, as well as intense selective pressures due to the host 
immunity and drug therapy [2], [3]. These phenomena have been investigated in a 
range of human pathogens impacting global health, including Human 
Immunodeficiency virus (HIV) [4] and Influenza A viruses (IAV) [5]. 
Viruses are great model organisms for evolutionary biology, not only because 
they have broad implications on global health and biogeochemical processes, but also 
for addressing fundamental questions. Viruses have relatively simple and compact 
genomes due to the constraint of being dependent on cellular organisms for 
replication. Thus, their genomes are the simplest system to model complex genome-
wide interactions such as epistasis and clonal interference [6]. Viruses also are the 
smallest microbes that are at the boundary of living and non-living; thus they provide 
a key platform to understanding the central biological questions such as the origin of 
life, recombination, selfish elements, and host-pathogen coevolution [1], [7], [8].  
Recent advances in data production and data analysis relating to the field of 
genetics open an opportunity to investigate these questions using big genomic datasets 
and novel computational methods [9]. In this chapter, the potential of viruses as a 
model organism is explored from the perspective of experimental evolution to that of 
global virology. 
 
1.1 Experimental evolution of viruses 
 
Viruses evolve in a complex cycle of transmission between hosts; thus, it is hard to 
predict the evolutionary trajectory of these pathogens in nature. To better understand 
the evolution of pathogens on a population-scale (or even on a global-scale), 
experimental evolution procedures have been developed as the simplified version of 
the complex world. Since these procedures control the environment during evolution, 
the number of necessary assumptions is minimized [10]–[12]. Furthermore, since the 
genome evolution of these pathogens can be observed temporally, more biological 
factors can be integrated into evolutionary models. For example, critical evolutionary 
processes such as drift, epistasis, clonal interference, and large offspring variance can 
be considered, factors that have mainly been ignored under large-scale pandemic 
models. These experimental studies may elucidate how pathogens evolve at larger and 
more complex scales in nature.  
The standard procedure for experimental evolution of pathogens is to serially 
passage the microorganism in cell cultures under the presence or absence of a given 
treatment (i.e., drug/disinfectant agent). Samples of the pathogen are then collected 
and sequenced in a time-serial manner, and temporal allele trajectories of all 
nucleotides are generated. Due to the small size of virus genomes, population-level 
whole-genome sequences are accessible at low cost. These datasets are analyzed with 
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the goal of estimating population genetic parameters such as effective population size 
(Ne) and selection coefficients (s). These parameters are essential in experimental 
evolution, as temporal changes in allele frequency can be deterministic due to fitness 
advantages (selection), or stochastic due to finite population sizes (genetic drift). 
Other model parameters such as mutation rate and recombination rate are important 
for understanding these processes that increase genetic variations enable viruses to 
adapt to new environments. 
 
1.2 Model parameters in virus genome evolution 
 
In virus genome evolution, a number of efforts have been made recently to infer 
parameters such as effective population size (Ne), selection coefficients (s) and 
mutation rate (µ) from time-sampled experimental evolution data [10]–[13]. These 
methods are mostly based on the Wright-Fisher model (where population census size 
is assumed to be constant and discrete, utilizing random sampling of biallelic gene 
copies), with different approximations to infer population genetic parameters from 
temporal allele trajectories. These model parameters are the first steps to 
understanding the landscape of virus evolution, with the eventual goal of finding 
solutions to the problems of global viral epidemics. For example, the inference of 
effective population size (Ne), selection coefficients (s) and mutation rate (µ) in an 
experimental evolution setting may provide the initial clues of the potential threat of 
viral pathogens adapting to a new drug or treatment in nature [10]–[13].  
 
Wright-Fisher model 
The Wright-Fisher model is one of the most fundamental models proposed by Sewall 
Wright and R.A. Fisher to represent the random process of allele frequency changes 
in finite populations [14], [15]. The model generalizes the genetic drift of alleles from 
one generation to the next as a binomial distribution, in the absence of other 
evolutionary processes such as selection, gene flow, and mutation. The binomial 
distribution defines the probability of sampling k alleles in a sample of N: 
 Pr 𝑋 = 𝑘 = (!!)𝑓!(1− 𝑓)!!!        (1) 
 
where f is the allele frequency. For viruses, N represents the haploid population size. 
The assumptions made to simplify this process in virus population dynamics include 
discrete and non-overlapping generations, constant population sizes, and independent 
alleles. In the absence of other forces, the probability that an allele gets fixed in the 
population under genetic drift is equivalent to its initial allele frequency. The general 
consequences of the Wright-Fisher model in modeling genetic drift in finite 
populations are: the change in allele frequency due to genetic drift is random, the 
magnitude of genetic drift is bigger in smaller populations, and an equilibrium state of 
a population under the influence of only genetic drift is fixation or loss of an allele. 
 
Effective population size 
The census population size N is the number of individuals in a population – however, 
not all individuals contribute to the changes in allele frequency in most biological 
populations. Thus, the genetic size of a population is defined as the effective 
population size Ne, which is proportional to the magnitude of genetic drift. Ne can be 
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of genetic drift in an idealized population under the assumptions of the Wright-Fisher 
model.  
There are two ways to estimate the effective population size of a sample 
population: Inbreeding effective population size (Nei) and Variance effective 
population size (Nev). The estimates from these two definitions of effective population 
sizes may differ when model assumptions for each definition are not met. For viruses, 
only the concept of the variance effective population size is relevant as viruses are 
haploid populations. The variance effective population size, Nev, can be estimated 
through expressing the changes of allele frequency over time in many replicates as a 
variance: 
 𝑉𝑎𝑟 ∆𝑓 = 𝑓!!!(1− 𝑓)!!!2𝑁𝑒!        (2) 
 
where f is the allele frequency of an allele of interest, and t is the number of 
generations. 
 When the population size fluctuates over time, as it does occur in viruses inter-
host population bottlenecks and intra-host population growth during infection, the 
effective population size can be calculated using the harmonic mean: 
 1𝑁𝑒 = 1𝑡 1𝑁𝑒! + 1𝑁𝑒! +⋯+ 1𝑁𝑒!        3  
 
where t is the total number of generations over the fluctuating sizes. This harmonic 
mean gives more weight to small values due to the inverse of population size – thus, 
the genetic bottleneck is an important factor in determining the strength of genetic 
drift in a population over time.  
 
Selection coefficient 
Natural selection occurs when one phenotype causes a greater chance of survival and 
reproduction and the genotype that causes this phenotype increases in frequency over 
generations. The fitness of an individual can be defined by absolute fitness or relative 
fitness. Assuming two genotypes A and B, the absolute fitness of A is given as: 
 𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑓𝑖𝑡𝑛𝑒𝑠𝑠 𝑜𝑓 𝐴 = 𝑁!𝑁! + 𝑁!        (4) 
 
where NA + NB is the total population size. Alternatively, the ratio of genotype-
specific growth rates of A to B is given as the relative fitness: 
 𝑁! 𝑡𝑁! 𝑡 = 𝑤! 𝑁! 0𝑁! 0        5  
 
where w is the strength of natural selection and t is the number of generations. When 
w > 1, the genotype B is growing faster than the genotype A, and when w < 1, the 
genotype A is growing faster than the genotype B. Thus, the change in the frequency 
of the genotype A due to natural selection is given as: 
 ∆𝑓! = 𝑓!𝑤!𝑓!𝑤! + (1− 𝑓!)𝑤! − 𝑓!       (6) 
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 𝑠! = 1− 𝑤!       (7) 
 
where ft is the frequency of the genotype A at the generation t. As shown above, 
fitness can be expressed in terms of selection coefficient, 𝑠!, by taking the difference 
between the relative fitness and one. As viruses are entirely dependent on host cells 
for replication, they experience strong selective pressures during viral life cycles due 
to host immunity and/or drug treatment, both in experimental evolution and in nature. 
 
Mutation rate 
Since mutation is the ultimate source of genetic variation for all organisms, there has 
been much effort to understand the effect of mutation rate on the course of evolution. 
For host-dependent viruses, mutation is a vital mechanism for switching between 
hosts and evading host immune system. Particularly in experimental evolution, it is 
common to start serial passaging of viruses with a clonal population [10]–[12] – thus, 
the high mutation rate of viruses is responsible for creating the diversity of a virus 
population over the course of evolution. To calculate the mutation rate, the pairwise 
nucleotide diversity of an idealized population is assumed to be directly proportional 
to 𝜇𝑁!, where Ne is the effective population size, and µ is the mutation rate, according 
to the neutral theory of molecular evolution [16].  
Recent evidence at whole-genome and single-gene levels shows that mutation 
rates tend to evolve by selection to improve replication fidelity, whose variation is in 
turn created under random genetic drift [17]. This theoretical work on the mutation-
rate evolution is based on the fact that most mutations are deleterious [16], which is 
especially true for viruses whose genome is compact and dedicated only to protein-
coding. A mutator that increases mutation rate (such as a DNA polymerase variant, or 
a DNA repair protein) is subjected to the opposing forces of mutation pressure (input) 
and selection/recombination (output) [17]. The degree to which selection can reduce 
the mutation rate is dependent on the effective population size (Ne) that determines 
the strength of genetic drift. This drift-barrier hypothesis postulates that when the Ne 
is small – thus, with strong genetic drift – the efficiency of selection in removing 
mutators decreases. For example, when viruses are subjected to mutagenic agents that 
increase mutation rate above the natural equilibrium, the response of virus genomes to 
such a rapid change in this vital mechanism is found to influence the effectiveness of 
these treatments against viral pathogens [12].  
   
Recombination rate 
Recombination is the exchange of genetic materials between chromosomes, and 
sexual reproduction is the production of new organisms by combining genetic 
information from two parents through recombination [18]. Recombination occurs in 
diploid eukaryotic organisms during reproduction, and also in prokaryotic cells and 
viruses when genetic material is transferred from a donor to a recipient. 
Recombination generates genetic variation and is also involved in other functions 
such as DNA repair. The ubiquity of recombination and sexual reproduction across 
the tree of life is one of the biggest questions in evolutionary biology. Evolutionary 
explanations for the advantages of recombination argue that it generates greater 
variability by breaking down genetic associations [19]. 
 Viruses undergo genetic change by antigenic drift (point mutation) and 
antigenic shift (recombination or re-assortment). Genetic recombination is frequent in 
both RNA and DNA viruses and occurs at highly variable rates. For example, the rate 
of recombination per nucleotide in Retroviruses (ssRNA-RT) like HIV exceeds that of 
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mutation, though it can vary from high to nonexistent in other RNA viruses [7]. 
Similarly, segmented viruses exhibit re-assortment rates ranging from low (e.g., 
Hantaviruses) to high (e.g., influenza A virus) [7]. 
 Recombination/re-assortment allows viral genomes to undergo major genetic 
changes during evolution, such as increasing virulence and pathogenesis, evading host 
immunity, altering transmission tactics, expanding host ranges, evolving antiviral 
resistance, and potentially creating new viruses. There is an ongoing debate on 
whether recombination is a form of sexual reproduction for viruses, as is for cellular 
organisms [7]. Despite the extensive results that the benefits of recombination are 
responsible for the ubiquitous presence of sexual reproduction [19], the viral 
community asserts that there is little evidence of recombination being favored by 
natural selection for viruses and that it is a mechanistic by-product of other aspects of 
viral biology [7].  
Recombination is a particularly important event in the viral epidemic since it 
allows viral genomes to undergo major genetic changes. Furthermore, viral genomes 
are almost entirely functional which makes most mutations deleterious. 
Recombination is therefore essential for breaking down negative genetic associations 
in these cases, as any advantageous allele is likely to be linked with other deleterious 
mutations. Other stochastic events such as genetic drift (due to small effective 
population sizes within hosts) and sweepstake events (due to stochastic variation in 
reproductive success) during host-to-host transmission are significant factors 
impacting the prediction of viral evolution. 
 
1.3 From experimental evolution to global virology 
 
We can build on the knowledge acquired from experimental evolution to study the 
complex and extensive network of viruses in nature, with the goal of predicting the 
evolutionary trajectories of viruses on a global scale. Furthermore, the population 
genetic knowledge acquired from the experimental evolution studies may help 
investigate the role of viruses in the long-term evolution of various ecological 
systems, such as microbial communities and human microbiota, given the ubiquitous 
presence of viruses. Investigating viral biology on a global scale is important for the 
following reasons. 
Firstly, viruses have the potential to become a threat to global public health as 
shown by the recent outbreaks of Ebola virus1 and Zika virus2, aided by the ever-
increasing mobilization of human populations. Moreover, the possibility of air-borne 
and water-borne transmission shows how these pathogens can transmit rapidly 
between their hosts. The emergence of new viruses may occur unpredictably by 
forming new subtypes through antigenic drift and/or antigenic shift. In viral 
epidemiology, the recent advances in genetic data production and analysis are helping 
to predict the evolutionary path of viral pathogens, based on the previous data and 
intricate models [20], [21].  
 Secondly, viruses play vital roles in the biochemical processes of global 
microbiota. It is estimated that marine viruses are responsible for over one-third of 
host mortality per day through lysing host cells, and over 1,000 gene movements per 
day through horizontal gene transfer [22]. In cold environments, the impact of 
virulence and viral-host evolution on soil biogeochemical cycling is limited – 																																																								1 Ebola virus disease. (2019.02.01). Retrieved from https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease 2 Zika virus. (2019.02.01). Retrieved from https://www.who.int/news-room/fact-sheets/detail/zika-virus 
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however, the conditions in cold soils such as permafrost and glaciers are changing due 
to accelerated climate change. The impact of viruses continues to increase on the 
ecosystem of microbiota in climate-sensitive areas. Thus, investigating viral 
abundance and diversity to characterize the Earth’s virome through metagenomic data 
is vital [23]. 
 Thirdly, viruses have vast implications in the evolution of the Earth’s biomes – 
the role of viruses is essential is evolving and regulating microbial communities, and 
the extent of its influence is ongoing research. Phages are viruses that infect microbes, 
and virus-host interactions result in coevolution that often leads to biological 
novelties. Phages are selfish replicators that propagate their genomes through 
infecting microbes – thus, microbes evolve defense mechanisms such as CRISPR/Cas 
adaptive immune system against phage infections, and phages co-evolve to evade 
these mechanisms [24]. Viruses have two distinct states of reproduction: virulent 
(lytic) and temperate (lysogenic) [25]. Lytic phages affect the mortality of microbes, 
and this is the major force behind the organic matter cycling in various ecosystems. 
Lysogenic phages are integrated into the chromosome of microbes, and these 
prophages replicate together with their hosts. As the fitness of prophages is directly 
linked to their host, new dynamics between hosts and pathogens arise, such as 
inhibiting superinfection of the host by other phages and providing virulence factors 
to their hosts to invade new niches. Lysogeny can also gradually enable phages to 
evolve from lytic phages (complete selfishness) to cryptic phages (complete 
domestication) where they become unable to form infective particles and evolve as 
one selectable unit with the host. 
 
1.4 Likelihood-free inference in virus genome evolution 
 
Advances in genomics allow the scientific community to move from small-scale 
inference such as experimental evolution to large-scale inference such as viral 
epidemics. In conventional evolutionary models, statistical inference with analytic 
approaches has been the focus of data analysis. However, it may be difficult to 
compute likelihood functions from models with many latent variables and/or complex 
architecture [26]. This problem is particularly prevalent in biological modeling since 
biological systems in nature tend to be very complex– such as phylogenetic trees, 
gene networks, and ecology systems to name a few. Thus, numerous likelihood-free 
methods have been developed to overcome this limitation in model-based inference, 
including Approximate Bayesian Computation, where a likelihood function is 
replaced by simulation [27]–[29], and Variational Inference, where intractable 
integrals are approximated using standard probability distribution [30], [31]. This 
chapter discusses some of the popular simulation-based methods used to infer the 
parameters of a statistical model, with a particular focus on their application in 
virology. 
 
1.4.1 Approximate Bayesian Computation 
 
One of the best ways to describe observed data is by fitting a statistical model with 
known or/and unknown parameters. In Bayesian frameworks, the inference of model 
parameters from data is carried out by computing the posterior distribution 𝑃 𝜃 𝐷𝑎𝑡𝑎) from the prior distribution 𝑃(𝜃) and likelihood function 𝑃 𝐷𝑎𝑡𝑎 𝜃  as 
follows: 
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 𝑃 𝜃 𝐷𝑎𝑡𝑎) = 𝑃 𝐷𝑎𝑡𝑎 𝜃 𝑃(𝜃)𝑃(𝐷𝑎𝑡𝑎)         (8). 
 
However, when the model is very complex, as in population genetics, the exact 
likelihood calculations can become intractable due to the presence of latent variables 
or heavy computation [26]. Approximate Bayesian Computation (ABC) is used to 
overcome this problem [32], [33]. ABC replaces likelihood calculations by simulating 
the model of interest directly with random input values from its prior distribution 
(Figure 1). This allows very complex models to be inferred since simulating them 
with a set of input values is much easier and faster than calculating the likelihood of 
each parameter space [32]. These simulations are classified using summary statistics, 
which are then compared to observed data to construct a posterior distribution for the 
parameter of interest (Figure 1).  
 In ABC, summary statistics are used to summarize high-dimensional data such 
as a sample of multivariate measurements into low-dimensional statistics comparable 
to the observed values. However, as the number of summary statistics increases to 
describe complex data more accurately, a “curse of dimensionality” occurs in which 
most simulations get rejected due to increasing dimensionality. For example, if three 
summary statistics are accepted with 10% tolerance, 99.9% of the simulations will be 
rejected due to the three-dimensional tolerance space [26]. Furthermore, an 
unspecified loss of information by using insufficient summary statistics may lead to 
the problem of choosing the wrong model with ABC [34].  
 ABC model choice is used to choose between two models: M0 as a null model, 
and M1 as an alternative model. The relative probability of M1 over M0 can be 
computed through the model posterior ratio as the Bayes factor B1,0 [33]: 
 𝑝(𝑀!|𝐷)𝑝(𝑀!|𝐷) = 𝑝 𝐷 𝑀! 𝑝(𝑀!)𝑝(𝐷|𝑀!)𝑝(𝑀!) = 𝐵!,! 𝑝(𝑀!)𝑝(𝑀!)         (9) 
 
when the model prior 𝑝(𝑀!) is equal to 𝑝(𝑀!). In practice, the model priors are made 
equal by producing the same number of simulations for each model and retaining the 
best simulations from the combined simulations. In ABC model choice, the posterior 
ratio is computed as the number of accepted simulations from M1 over those of M0 – 
giving the Bayes factor B1,0 which is an indicator of the support for a specific model.  
 As ABC has become an important tool for inferring parameters with complex 
models, many efforts are being made to improve the method [33], including 
integrations of Markov Chain Monte Carlo (MCMC) [29] and Hamiltonian Monte 
Carlo (HMC) [35]. These methods increase the power of ABC inference by 
improving the random sampling of input values from the prior distribution of a 
parameter. Markov Chain Monte Carlo (MCMC) is a widely used algorithm for 
sampling and attempts to solve the problem of sampling from a complex distribution. 
Biological models are particularly complex, thus sampling from a complex 
distribution used to represent these models leads to the problem of the probability of 
drawing a desired outcome very low. Thus, MCMC is introduced as a randomized 
algorithm that makes the sampling process more efficient by making the probability 
of sampling an output approximately equal to the target probability distribution. There 
are two steps in this algorithm: 1. Monte Carlo step which is a random walk taking a 
large sample, 2. Markov Chain step which estimates the expectation of the probability 
distribution. Examples of Monte Carlo methods include Metropolis-Hastings 
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algorithm that uses a proposal density for the next move that can be accepted or 
rejected and Gibbs sampling that uses the conditional distributions of the target 
probability distribution. These methods are particularly efficient when sampling from 
high-dimensional distributions. 
 
1.4.2 Simulation-based inference in virology 
 
Simulation-based methods such as Approximate Bayesian Computation (ABC) are 
particularly useful in population genetics, where models to represent the forces of 
evolution (genetic drift, selection, gene flow, mutation) at a population-level become 
complex and dynamic. For this reason, the applications of ABC have been pioneered 
and widespread in population genetics – to name a few, for inferring growth rates and 
time of divergence from genetic data, and for model choice between competing 
models of human demographic history [26]. Other examples of ABC in the fields of 
evolution and ecology include phylogeography, systems biology and epidemiology 
[26].  
 In virology, simulation-based methods have been successfully applied to infer 
population genetic parameters such as effective population sizes and selection 
coefficients from the Wright-Fisher models. For example, according to the simulation 
studies comparing the performance of different time-serial methods for inferring 
population genetic parameters, the simulation-based method is shown to perform the 
best for virus populations that experience high selective pressures due to their 
dependency on host cells [36].  
 Despite their practicality, the performance of simulation-based methods is 
limited to the particular model used for inference. For example, the Wright-Fisher 
model used in these inference studies assumes mutations arising in the course of 
evolution of viruses are completely independent. This assumption is not valid even in 
the simplest organisms like viruses, especially because their genomes are entirely 
functional, making potential interactions between mutations prevalent through 
compensation (epistasis) or competition (clonal interference). Thus, the conventional 
model-based inference, including simulation-based methods, has limited abilities to 
learn new features biological from data.  
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2 Artificial Neural Networks 
 
Artificial Neural Networks (ANN) is a model-free approach that has a great potential 
for applications to big genetic data. Deep learning using Artificial Neural Networks is 
a subfield of machine learning, where computers are able to extract patterns from raw 
data and acquire their own knowledge of the real world. This task is done by 
representing data as a piece of information known as a feature – for example, the 
features about a patient such as the previous medical records enable machine learning 
algorithms to predict the diagnosis of the patient. However, it is often difficult to 
manually extract the best features that might be useful for machine learning 
algorithms. This downside is particularly problematic in complex tasks such as 
recognizing objects in pictures since these objects such as cars or dogs can take 
various shapes and colors. One solution is to use a machine learning technique called 
representation learning to learn features themselves instead of only mapping 
representation to output [37]. However, extracting high-level features from raw data is 
not an easy task. Deep learning tackles this problem by expressing representations in 
terms of simpler representations in a hierarchical manner. This advantage provides a 
flexible framework where features are easy to adapt and learn, without manual over-
specification of features like other machine learning techniques. Historically, the 
fundamental ideas and architectures of deep learning have been inspired by biological 
neural networks in the brain; hence it goes by the name of Artificial Neural Networks 
or Multilayer Perceptron (MLP) or Feedforward Deep Network. In this chapter, the 
basic concepts of artificial neural networks are introduced, leading to the discussion 
of their potential applications in virology. 
 
2.1 Feedforward Neural Networks  
 
The goal of neural networks is to approximate a function 𝑓∗. A feedforward network 
defines a mapping 𝑦 = 𝑓(𝑥;𝜃) and learns the parameters θ that result in the best 
function approximation. In this feedforward, the information flows from the input x 
through the intermediate computations defining f to the output y, with no feedback 
(unlike recurrent neural networks). In mathematical terms, a multilayer perceptron is a 
function mapping input to output, which is composed of simpler functions. For 
instance, a multiplayer perceptron may be composed of a chain of three functions 𝑓(!), 𝑓(!), and 𝑓(!); 
 𝑓 𝑥 = 𝑓 ! (𝑓 ! 𝑓 ! 𝑥 )       (10) 
 
where x is the input, 𝑓(!) is the first hidden layer, 𝑓(!) is the second hidden layer, and  𝑓(!) is the output layer of the networks as shown in Figure 2. The length of the chain 
is called the depth of the network, and it is where the concept of “deep learning” 
arises.  
Within a neuron, an elementary unit shown as blue circles in Figure 2, the input 
values in each hidden layer are multiplied by their corresponding weights (w) and 
added by a constant bias term (b): 
 𝑓 𝑥;𝑤, 𝑏 = 𝑥!𝑤 + 𝑏       (11) 
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where the function used in hidden layers is called the activation function. Weights 
control the strength of connection and bias offsets the output while independent of 
data. Depending on the neural networks, the activation function can take diverse non-
linear forms such as sigmoid 𝑓 𝑥 = 1 (1+ 𝑒!!)  or ReLU 𝑓 𝑥 = max (0, 𝑥) 
functions. During training, the data provide noisy and approximate examples x of 𝑓∗(𝑥) to drive 𝑓 𝑥  to match 𝑓∗ 𝑥 . The output layer must produce a value close to y 
without being told what intermediate layers should do (thus called hidden layers) – 
the learning algorithm implements an approximation of 𝑓∗.  
 
2.2 Training Neural Networks 
 
To train neural networks, we need to do the following steps: 
1. Define a loss function (=cost/objective/error function) that quantifies the 
inconsistency between predicted value 𝑦 and actual label 𝑦. 
2. Find the parameters that minimize the loss function (optimization) 
 
2.2.1 Loss function 
 
Given the dataset (𝑥! ,𝑦!) !!!! , where 𝑥! is the input and 𝑦! is the output/label, the loss 
over the dataset is a sum of loss over the examples: 
 𝐿 = 1𝑁 𝐿!(𝑓 𝑥! ,𝑊 ,! 𝑦!)       (12) 
 
Furthermore, the loss function has a regularization term (for example, L2 
regularization tends to prefer smaller and spread out weights W) that imposes a 
penalty on the complexity of a model to prevent overfitting. 
 𝑅 𝑊 = 𝑊!,!!!!        (13) 
 
Thus, the loss function is given as: 
 𝐿 𝑊 = 1𝑁 𝐿! 𝑓 𝑥! ,𝑊 ,𝑦!!!!! + 𝜆𝑅 𝑊       (14) 
 
where λ is the regularization strength, which is a hyperparameter to be chosen. 
 
2.2.2 Optimization 
 
In order to find the values of W that reduce a loss function, we can use the gradient 
descent: 
 𝑑𝑓(𝑥)𝑑𝑥 = lim!→! 𝑓 𝑥 + ℎ − 𝑓(𝑥)ℎ        (15) 
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The computation of an analytic gradient is fast and exact but error prone. The 
computation of a numerical gradient is easy to write, but slow and approximate. To 
overcome the challenges of computing gradients over a huge neural network, the 
backpropagation algorithm computes the gradient cheaply by allowing the 
information from the cost to flow backward through the network. It works by splitting 
the gradient into local gradients with the chain rule to iteratively compute gradients 
for each layer. 
 
2.3 Artificial Intelligence in virology 
 
The concept of Artificial Intelligence (AI) arises from the futuristic vision that 
machines can become intelligent by having the ability to learn and reason like 
humans. Two aspects of modern society are driving AI to be a thriving field - 
computational power and big data. Computational biologists also envision 
programmable computers that can mimic human intelligence to learn from biological 
data in the near future. The application of machine learning methods in biological 
systems allows model-free investigations, particularly through the rapid progress in 
deep learning, where neural networks are used to learn functional relationships from 
observed data [38]. Deep learning has the potential to solve complex problems such 
as predicting viral epidemics using big genomic datasets, through multilayer neural 
networks, which were previously thought infeasible [38].  
Statistical models in viral epidemics have to consider multiple factors and make 
strong assumptions, due to the complexity of viral biology, host biology, and host-
pathogen interactions. As viruses only replicate within their hosts, they tend to evolve 
either a symbiotic relationship with their hosts that may be antagonistic (pathogenic), 
commensal (hitchhiking), and mutualistic (beneficial) [39]. This complexity in the 
viral life cycle makes the prediction of viral epidemics difficult, as predictive models 
have to incorporate events that occur at the micro-level within hosts and the macro-
level between hosts. For instance, these models have to consider viral biology that is 
highly diverse between different virus types such as in virulence, replication, and 
recombination at the micro-level [1]. Furthermore, there are population genetic 
factors such as effective population size, mutation rate, and host defense systems that 
affect the evolutionary trajectories of viruses even within the same virus type. 
Additionally, these models have to incorporate factors that affect the transmission 
between hosts at the macro-level, such as migration patterns and transmission routes 
of their hosts.  
 Despite recent efforts, model-based methods have difficulties in incorporating 
these factors due to the complexity of solving or simulating these models [40]. 
Furthermore, these model-based methods do not take full advantage of hidden 
patterns in high dimensional biological data and/or big genetic data. To solve intricate 
problems such as viral epidemics, machine learning methods are promising tools to 
drive model-free and data-driven research to mine hidden patterns and make accurate 
predictions. Artificial neural networks are particularly useful for such problems, as 
they can extract features from data in a hierarchical manner [37]. 
We now have access to big genomic datasets that are essential resources for 
machine learning approaches. For example, Influenza Research Database (fludb.org) 
currently has 661,000 segment sequences available3, which offers a great opportunity, 
but also an overwhelming challenge for traditional model-based approaches. Indeed, 																																																								3 Influenza Research Database. (2019.01.30). Retrieved from https://www.fludb.org/brc/dataSummary.spg?decorator=influenza 
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the scientific bottleneck no longer occurs at the level of genomic data production, but 
rather at the level of data analysis. Moreover, other big data such as digital 
epidemiology and global human migration patterns are growing exponentially. Using 
artificial neural networks and genomic sequences from the Influenza Research 
Database, a predictive platform may be generated at the micro-level and/or micro-
level. Using influenza virus (IAV) genome sequences and other epidemiologic data 
from the previous years as training examples, an algorithm may be designed to predict 
IAV strains likely to be prevalent in the following year. The current challenge is to 
curate different types of data as input and to design the architecture that can integrate 
both the events that happen at the micro-level within hosts and at the macro-level 
between hosts.  
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3 Third-Generation DNA sequencing 
 
In the field of biology, advances in technology and engineering are expanding the 
scope of questions that can be investigated with theoretical and computational tools. 
For example, DNA sequencing is becoming more efficient, accurate, and cost-
effective each year, such that a human genome can be sequenced for only $1,000 at 
30x coverage, and at a speed of 18,000 genomes per year4. This innovation is 
phenomenal considering that the first full sequencing of the human genome was only 
completed in 2003. These rapid improvements in DNA sequencing allow more 
samples to be collected, from different individuals and/or at different time points.  
 Since the emergence of the Second Generation Sequencing in the late 1990s, 
lowered costs and improved efficacy of DNA sequencing is enabling the production 
of multiple time-point datasets [41], which are particularly revealing for the studies 
conducted in the domains of ancient DNA [41], experimental evolution [36], and 
clinical trials [42]. These datasets allow temporal observation of rapidly evolving 
organisms at different time-points in the past [10]–[12]. The studies of virus genome 
evolution benefit from the information on the temporal aspects of evolutionary forces, 
such as changes in selection, population sizes, or mutation rates [10], [12], [13]. 
Moreover, we can gain insights into the complex aspects of evolutionary trajectories, 
such as host-pathogen interactions or intra-/inter-species competition and cooperation.  
 Big genetic data generated from multiple individuals provide the means to 
investigate the genetic variants of a population, as shown by the success of genome-
wide association studies (GWAS) [43]. For viruses, sampling multiple individuals at 
the whole-genome level is feasible due to the small genome size of viruses. However, 
most virus datasets have been produced with the technique of pooled sequencing, 
where genetic materials from several individuals are pooled for sequencing. While 
this method of pooled sequencing is cost-effective and time-efficient, individual 
haplotypes cannot be reconstructed as in individual sequencing [12]. The novel 
technologies of long-read sequencing are pioneering platforms to generate the genetic 
data from multiple individuals cost- and time-effectively, including viral pathogens. 
In this chapter, the recent advances in sequencing technologies and their impact on 
virus research are introduced. 
 
3.1 DNA sequencing technologies 
 
First-Generation Sequencing (1970) 
The structure of DNA was first modeled by James Watson and Francis Crick in 1953 
[44], based on X-ray results by Rosalind Franklin. The first method of DNA 
sequencing was developed in the 1970s [45], [46], and the method developed by 
Frederick Sanger et al. in 1977 was introduced as one of the first commercially 
available techniques known as Sanger sequencing [46]. This method uses the 
selective incorporation of chain-terminating dideoxynucleotide (ddNTPs: ddATP, 
ddGTP, ddCTP, ddTTP) by DNA polymerase during in vitro DNA replication. 
Sanger sequencing was the most widely used sequencing method for the next 40 
years. 
 
 																																																								4 HiSeq XTM Series of Sequencing Systems. (2016.02.10). Retrieved from http://www.illumina.com/content/dam/illumina-
marketing/documents/products/datasheets/datasheet-hiseq-x-ten.pdf 
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Second-Generation Sequencing (2000) 
By the year 2000, several new platforms were developed to achieve high-throughput 
sequencing method for DNA sequences. One of the most commercially successful 
products is from Illumina’s Hi-Seq sequencers, which uses clonal amplification and 
sequencing by synthesis to allow parallel sequencing. The development of second-
generation sequencing enabled more efficient and accurate DNA sequencing for a 
lower cost, for example, lowering the cost of sequencing a human genome from US$1 
million down to US$4,000 by 2013. Additionally, the rapid data production of DNA 
sequences has pushed the scientific community to develop new computational 
methods for sequence processing, storage, and analysis.  
 
Third-Generation Sequencing (2015) 
Most recently, another innovation in DNA sequencing has emerged using new 
methods that allow long-read sequences, as compared to the previous methods. The 
most notable techniques are Single-Molecule-Real-Time (SMRT) sequencing and 
Nanopore sequencing. SMRT sequencing is based on sequencing by synthesis, where 
DNA sequences are synthesized in small containers at the bottom of the well, and 
fluorescently labeled nucleotides are incorporated by DNA polymerase to be detected 
by the smallest light detector volume in the well. Nanopore sequencing detects the 
changes in ion current of a nanopore when a DNA sequence passes through it. Both 
technologies are revolutionizing DNA sequencing by the production of long-read 
DNA sequences (>10,000 nucleotides as compared to typically 100 nucleotides in the 
Second Generation Sequencing) in real-time. 
 
3.2 Long-read sequencing for virology 
 
The Third-Generation DNA sequencing has emerged in the last few years using new 
technologies that allow the generation of substantially longer read sequences. In 
particular, the portable Nanopore sequencing device, MinION, can be used for de 
novo sequencing and metagenomics, and they are being tested for high-impact 
environmental research and pathogen analysis [47], [48].  
 Only a few years after the successful launch of the long-read sequencers, the 
scientific community is experiencing a rapid change in how genetic data are generated 
at the frontier research topics. For instance, since the first paper appeared in 2013 
with the keyword “Nanopore” at the preprint server for biology5, the number of 
papers with the same keyword has been doubling every year until 2018 as shown in 
Table 1. At this trend, genetic studies with the Third-Generation sequencing are 
expected to become the norm of genetic research studies in a few years.  
In virology, such innovations are also pervasive – various viruses are being 
sequenced with the long-read sequencer, including Ebola virus, chikungunya virus, 
dengue virus, yellow fever virus, and influenza A virus to name a few [48]–[52]. 
Since virus genomes are small and compact, long-read DNA/RNA sequences 
(>10,000 nucleotides) cover the complete genomes of many viral pathogens. Viral 
identification is made more efficient and accurate through such sequences in 
metagenomic samples. Other than reading long-read sequences, the Third-Generation 
sequencers such as Nanopore have further advantages for virus sampling. The 
portability and cost-effectiveness of these sequencers are enabling rapid and field-
based analysis of pathogens on-site at resource-limited settings. For an epidemic 																																																								5	BioRxiv: the preprint server for biology. (2019.02.07). Retrieved from https://www.biorxiv.org/ 	
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response, early identification of the viral strain of a new outbreak is crucial in 
monitoring and containing the epidemic through effective vaccination [48], [52]–[54]. 
In the clinical setting, the capacity to sequence in real-time offers a revolutionary 
diagnostic tool for various viruses that can cause disease outbreaks in human [49], 
[51] and livestock [55], [56].  
Furthermore, the ability to sequence DNA/RNA directly facilitates the 
characterization of genetic plasticity by eliminating the PCR step, for investigating 
complex topics such as epigenetic modification and transcriptome profiling [57]–[59]. 
For instance, long-read sequencing has greater efficiency in sequencing full-length 
transcripts and identifying RNA isoforms [59]. In metagenomics, these advantages of 
highly parallel direct RNA sequencing also improve the assembly of viral genomes 
and the investigation of microdiversity [60]. As long-read sequencing is 
revolutionizing the quantity and quality of genetic data, an innovation in the down-
stream analysis using automated machine learning methods is an urgent task to 
achieve in computational biology. 
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4 Futuristic methods in virus genome evolution 
 
The scientific community is experiencing a rapid change in the research paradigms, 
both through the advances in data production and data science. An ever-increasing 
growth of big data is evident in a wide variety of research fields, from computer 
vision, astronomy, weather forecasting, health care, to genetics. To process such data, 
researchers are pushing the boundaries of computational power and method. Novel 
computational approaches such as machine learning methods are being developed to 
learn from big datasets, and these advances in data science are inspiring researchers 
from other fields to apply those methods in their respective datasets. In computational 
biology, researchers attempt to apply these novel methods using machine learning to 
process and classify high dimensional biological data, to predict future events or to 
acquire new knowledge.  
Model-free approaches such as machine learning methods eliminate the errors 
resulting from strong assumptions about underlying mechanisms by taking a data-
driven approach [40]. The digitization of society has opened the age of big data, 
making machine learning methods more attractive by lightening the key burden of 
statistical estimation from small datasets [37]. This data-driven research takes full 
advantage of the advances in data production by learning directly from the vast 
amount of data produced (unsupervised learning). Furthermore, model-free methods 
may change the focus of study from inference to prediction, as machine learning 
methods can be designed to learn from previous input-output pairs to predict the 
output from a new sample (supervised learning). Unlike inference, the performance of 
predictive algorithms may be assessed directly with future data.  
Advances in model-free approaches are particularly important for virus 
evolution. We aim to predict the course of viral pathogens efficiently and accurately 
from previous data, which is vital for critical societal and economic issues such as 
global public health and agricultural industry (supervised learning). Furthermore, we 
aim to acquire new knowledge on the ecology and evolution of viruses in various 
systems, through big genomic data of new viruses (unsupervised learning). In this 
chapter, the future of virology is discussed in conjunction with advancing sequencing 
technologies and data analyses, using specific examples in supervised learning and 
unsupervised learning setting. 
 
4.1 Futuristic big data analysis for virology 
 
The rapid increase in genetic data leading to the current challenge of dealing with big 
data is expected to accelerate with the Third-Generation sequencing technologies. 
Applications of long-read sequencing enable real-time data production without an 
intermediate data processing step, as shown in Figure 3. Until recently, considerable 
efforts have been devoted to the upstream data processing of the Second-Generation 
sequences - for assembly, alignment and quality control of short sequence contigs. In 
futuristic approaches, the conventional workflow of the Second-Generation 
Sequencing may be simplified into real-time data production and on-site data analysis 
using the Third-Generation Sequencing and machine learning analysis, respectively. 
This automatization is an important improvement to the diverse fields of virology 
such as experimental evolution as well as environmental and medical sampling 
campaigns. Long sequences from the Third-Generation sequencers eliminate the 
errors and uncertainties resulting from assembling short sequence contigs into a 
physical genome map in the Second-Generation sequencing. Thus, an innovation in 
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the downstream data analysis step is necessary to analyze large-scale data generated 
from real-time long-read sequencing (Figure 3).   
It is of a future challenge in computational biology to achieve automatized 
machine learning approaches that minimize human input to analyze real-time data 
from long-read sequencers on-site. Machine learning combines pattern recognition 
and computational learning to perform predictive data analysis. As shown in Figure 3, 
the application of neural networks innovates the downstream data analysis to process 
genetic data from the Third-Generation sequencing by big data analysis without 
model assumptions or feature specifications, as required in the classical 
bioinformatics.  
 
4.2 Supervised Learning: virus classification 
 
Supervised learning aims to predict an output from an input, based on previous input-
output pairs. It infers a relation that maps input data to output data by learning a 
function that maps them through labeled training examples. Thus, supervised learning 
requires a big set of labeled training examples and a great deal of effort is put into 
gathering and labeling a training set from human experts or automated measurements. 
For artificial neural networks, the step to represent raw data as features is not 
necessary, but the architecture of neural networks (i.e., the number of neurons and the 
depth of layers) is a major factor that influences the performance of supervised 
learning. Then, the learning algorithm can be run on the labeled training set to 
increase the accuracy of the learned function for an optimized prediction. The 
performance of the learned function is measured through a test set that is unseen 
during the training set. As mentioned before, the advantages of artificial neural 
networks in learning non-linear and complex functions over several layers of neurons 
[37] apply to high dimensional genetic data. 
 In virology, the potential of supervised learning using artificial neural networks 
is significant. Viruses display a vast diversity in form and function, and there are 
already virus genome datasets available, which are essential resources to design a 
comprehensive platform for virus classification using supervised learning. Viruses 
can have a vast functional diversity comparable to the corresponding microbial 
populations [61]. Applications of new sequencing technologies and advanced 
computational methods can improve the current knowledge of viruses by providing 
relevant data and techniques to test hypotheses.  
Despite their abundance, diversity and ecological significance in the biosphere, 
viruses are understudied in many ecological communities [62]. For example, the lack 
of knowledge on the impact of viruses is particularly relevant in rapidly changing 
ecosystems such as glaciers and permafrost [63]–[65]. Permafrost composes of 
approximately 25% of Earth’s land surface and stores almost 50% of global soil 
carbon in a frozen form. Near-surface permafrost across the Arctic region is rapidly 
thawing due to climate change [66]. Recent studies reveal that permafrost soils have 
an extensive presence and diversity of viruses – however, their impact on the 
microbial populations in this ecosystem of microorganisms is yet to be understood 
[67], [68]. On the other hand, glaciers cover approximately 10% of Earth’s land 
surface and host diverse microbial communities [64]. Along with surprising microbial 
diversity, viruses are also actively present in these cold ecosystems, with the rate of 
virus infection in these bacteria being one of the highest observed [65], [69]. Viruses 
in these permafrost- or glacier-covered soils experience strong selection pressures due 
to the extreme nature and isolation of these environments. Moreover, resident 
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microorganisms have other key roles in global biogeochemical processes such as 
methane cycling, fermentation, degradation of complex molecules and carbon gas 
emissions. However, the difference in virus diversity and activity in these two rapidly 
changing ecosystems is yet to be studied and assessed. Given the ever-increasing 
amount of sequence data generated through high-throughput technologies, large-scale 
comparative analysis with metagenomics is an invaluable tool to investigate viral 
diversity and activity from such environmental samples. As an example of the 
futuristic approach to investigate the viral impact on the ecosystem of cold soils, field 
sampling campaigns in permafrost regions using novel portable and real-time devices 
for long-read sequencing may be used. After which, these samples may be analyzed 
on-site in real-time using machine learning methods for supervised learning. This will 
help us understand the virome in these climate sensitive regions and examine the 
impending impact of thawing on the global biogeochemical cycling and coupled viral-
host evolution of microbial and viral communities.  
Specifically, we can envision a portable processor chip for virus classification 
on-site of such sampling campaigns.  In computer vision, one of the frontier fields in 
the application of neural networks, low-power and high-performance vision processor 
units including Movidius6 are already commercially available. These are vision 
processor units that carry out inference of new examples from a trained network at 
very low power. As training takes most of the time and computer power, deep neural 
networks have already been trained with millions of labeled examples of images to 
learn highly non-linear and complex functions for image classification. Thus, these 
devices deploying deep learning can classify new examples quickly on-site, as 
inference/prediction using pre-trained neural networks is a computationally cheap 
task. For instance, Movidius may be applied for intelligent machine vision systems 
such as robotics and augmented & virtual reality to classify images as quickly as 
human vision is able to do. A processor chip with similar purposes is an example of 
futuristic methods in studying virus genome evolution – a device containing deep 
neural networks pre-trained with the vast amount of labeled virus genomes. These 
portable devices may be used along with long-read sequencing to provide an 
integrated pipeline of real-time data production and on-site data analysis, as shown in 
Figure 4. A researcher can bring a portable long-read sequencer and a portable 
processor chip of neural networks pre-trained with virus genomes to field sampling 
campaigns, from which diverse viruses can be sequenced and classified on-site. In the 
near future, such devices will revolutionize how sampling campaigns for clinical and 
environmental samples are undertaken, advancing the efficiency and pace of global 
virus studies for diagnostic purposes as well as for basic research.  
 
4.3 Unsupervised learning: virus clustering 
 
One of the biggest advantages of artificial neural networks is its inherent capacity to 
extract features from raw data in a hierarchical manner [37]. The ability to extract 
features without strong assumptions or manual over-specifications makes artificial 
neural networks suitable for unsupervised learning. Unsupervised learning mines 
hidden patterns, structures, or features from unlabeled test data through methods such 
as clustering and autoencoders. Such methods are useful at the exploratory stage of 
new studies without access to labeled datasets, to search for innovative questions and 
acquire pioneering knowledge.  																																																								6	Movidius (2019.02.13). Retrieved from https://www.movidius.com/ 	
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 In virology, unsupervised learning is a largely unexplored field despite its 
potential to solve challenges arising in the downstream analysis due to the increasing 
rate of data production. Recently, a new approach has been developed to test the 
possibility of applying Artificial Neural Networks (ANNs) to virus genetic data [6], 
based on the results from the simulation-based inference of population genetic 
parameters from an experimental evolution study [11]. In the study, a simple neural 
network was applied to the genetic datasets to execute unsupervised learning of virus 
genome evolution. This method was able to infer evolutionary distances from raw 
genetic datasets under the presence or absence of selective pressures in the 
experimental evolution setting. Figure 5 summarizes the workflow of unsupervised 
learning of virus genome evolution with the Nucleotide Skip-Gram Neural Network 
[6]. The first step is to train the Nucleotide Skip-Gram Neural Network using the deep 
learning software, where the genetic interactions between all significant mutations 
from the experimental evolution of virus [11] are learned as features of the neural 
networks. Subsequently, Principal Component Analysis (PCA) and hierarchical 
clustering are applied to produce a pairwise correlation map of these features, which 
reflects pair-wise evolutionary distances between all the mutations arising in the 
course of experimental evolution. Thus, this study demonstrates that mutations can be 
represented as distributed vectors that encode information of biological features and 
can be learned from data with artificial neural networks, rather than discrete entities 
within classical population genetic models, such as the Wright-Fisher model. This 
study shows that unsupervised learning with neural networks can achieve the same 
level of exploratory knowledge by clustering mutations of similar evolutionary 
trajectories automatically [6], as the human expertise had obtained from a series of 
several experimental studies [11].  
In viral metagenomics, the features to learn are biological or evolutionary 
similarities that exist between billions of sequences in raw metagenomic data from 
different sources. Unsupervised learning from artificial neural networks has the 
potential to offer considerable benefits for futuristic data exploration: from field 
sampling of natural populations using the real-time sequencer to pattern mining of 
raw metagenomic data. This novel pipeline eliminates the intermediate step of data 
processing through the Third-Generation sequencing and the necessity of model 
assumptions through artificial neural networks. Therefore, these proposed futuristic 
methods have broad implications of improving field sampling and genetic data 
analysis, as well as of investigating the evolution and ecology of viral and microbial 
communities. 
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6 Tables and Legends 
 
 
Year 2013 2014 2015 2016 2017 2018 
BioRxiv 
“nanopore” 
papers 
1 13 38 87 170 323 
 
Table 1. The number of papers with the keyword “Nanopore” at the preprint server 
for biology (BioRxiv) from 2013 to 2018. 
 
 
 
 
Figure 1. Illustration of the Approximation Bayesian Computation (ABC). ABC 
simulates a model with a set of input parameters and compares its output values to the 
observation to build a posterior distribution of parameters of interest. 
 
 
 
 
 
Figure 2. Illustration of a fully-connected multilayer perceptron network. 
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Figure 3. Workflow of Second-Generation sequencing and analysis versus workflow 
of Third-Generation sequencing and analysis. 
 
 
 
 
Figure 4. Illustration of supervised learning for on-site virus classification with a pre-
trained processor chip. 
 
	 29	
 
 
Figure 5. Workflow of unsupervised learning of virus genome evolution with the 
Nucleotide Skip-Gram Neural Network. 
 
